[Sanevax: The following letter to the editors of Infectious Agents and Cancer was submitted as a response to “Potential impact of a nine-valent vaccine in human papillomavirus related cancers,” by Sylvia de Sanjosé, et al. After peer-review and approval, the letter was published in this month’s edition of Infectious Agents and Cancer.] Dear Editors In Chief: The article entitled […]
HPV Vaccines and Idiopathic Thrombocytopenic Purpura
By Norma Erickson Kirstie was only 12 years old when she was diagnosed with a rare disorder for which there is no known cure, Idiopathic Thrombocytopenic Purpura (ITP). This happened just a little over a month after her second injection of Gardasil. She will live with this disorder for the rest of her life. Unfortunately, […]
HPV Vaccine Safety: Has the CDC abandoned its mission?
By Norma Erickson What would happen if a vaccine turned out to cause more health problems than the disease it was meant to protect against? Are medical consumers watching this scenario unfold with HPV vaccines? The U.S. Center for Disease Control (CDC) states 90% of all HPV infections clear on their own with no symptoms […]
HPV Vaccines: Betrayal of the Public Trust?
By Norma Erickson, President Last week, multiple news articles reported 44% of American parents refusing Gardasil or Cervarix for their children. Between 2008 and 2010, the percentage of parents concerned about the safety of these two vaccines nearly quadrupled. As of 2010, only 32% of eligible girls were vaccinated against HPV. What is wrong with […]
Gardasil: New Study Brings More Safety Questions to Light
By Norma Erickson, President Why were HPV-16 L1 DNA fragments detected in post mortem samples taken six months after Gardasil vaccination and not the other vaccine-relevant types? Dr. Sin Hang Lee, of Milford Hospital and Milford Molecular Laboratory, may have provided an answer in his most recently published paper entitled, Topological conformational changes of […]
- « Previous Page
- 1
- …
- 18
- 19
- 20
- 21
- 22
- …
- 40
- Next Page »